---
title: "Top Irhythm Executives Cash In On Recent Insider Stock Moves"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291866862.md"
description: "Irhythm Technologies executives trimmed holdings in July 2026, with CMO Minang Turakhia and EVP Sean Clinton Freeman selling shares. Concurrently, Evercore ISI lowered price targets due to a measured outlook on MedTech procedure volumes, reflecting cautious near-term expectations rather than negative company-specific events. TipRanks' AI analyst rates IRTC as Neutral, citing balance-sheet leverage and bearish technical trends despite improved operating fundamentals."
datetime: "2026-07-07T02:03:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291866862.md)
  - [en](https://longbridge.com/en/news/291866862.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291866862.md)
---

# Top Irhythm Executives Cash In On Recent Insider Stock Moves

New insider activity at Irhythm Technologies ( (IRTC) ) has taken place on July 6, 2026.

Key executives at Irhythm Technologies have recently trimmed their holdings in the company. Chief Medical and Scientific Officer and EVP of Advanced Technologies, Minang Turakhia, sold 1,423 shares of Irhythm Technologies stock in a transaction valued at $177,462. In a separate move, EVP of Strategy & Corporate Development, Sean Clinton Freeman, disposed of 918 shares, generating sale proceeds of $114,483. These insider sales highlight notable activity among Irhythm’s senior leadership team.

Irhythm Technologies saw analyst price targets trimmed in the last day as Evercore ISI’s MedTech Q2 preview, while noting healthy procedure volumes and capital spending, led to a more measured outlook on the stock’s upside. The adjustment reflects cautious expectations about near‑term performance rather than any negative company‑specific event, with shares reacting to this tempered growth view.

**Spark’s Take on IRTC Stock**

According to Spark, TipRanks’ AI Analyst, IRTC is a Neutral.

The score is held back mainly by balance-sheet leverage and a clearly bearish technical trend, despite improving operating fundamentals and a positive earnings update with raised revenue and margin guidance. Valuation support is limited because earnings are still negative, and corporate events are mixed due to the legal settlement.

To see Spark’s full report on IRTC stock,  
click here.

**More about Irhythm Technologies**

**YTD Price Performance:** -28.72%

**Average Trading Volume:** 539,313

**Technical Sentiment Signal:** Buy

**Current Market Cap:** $4.16B

### Related Stocks

- [IRTC.US](https://longbridge.com/en/quote/IRTC.US.md)
- [EVR.US](https://longbridge.com/en/quote/EVR.US.md)

## Related News & Research

- [iRhythm Technologies (NASDAQ:IRTC) Raised to "Strong-Buy" at Stephens](https://longbridge.com/en/news/293750407.md)
- [iRhythm Technologies $IRTC Stock Position Lowered by Artisan Partners Limited Partnership](https://longbridge.com/en/news/290013059.md)
- [How the 'Nostradamus of AI' failed to spot a market crash](https://longbridge.com/en/news/294580418.md)
- [An AI exec is stepping down, citing workload and stress. Here's how 10 business leaders stave off burnout.](https://longbridge.com/en/news/294094773.md)
- [Qube Research & Technologies discloses net short position in 2CRSI](https://longbridge.com/en/news/294522107.md)